Sector › Medicine

Press Releases

中国抗体制药有限公司SM17治疗特应性皮炎1b期概念验证临床试验取得突破性结果

Apr 09, 2025 14:30 HKT/SGT

ライフサイエンスにおけるリスクアセスメントの習得: Tricentisが変革するデジタル検証

Apr 04, 2025 08:00 JST

JBM Healthcare Completes Acquisition of 90% Interest in Tin Hee Tong

Apr 03, 2025 17:30 HKT/SGT

健倍苗苗完成收購天喜堂90%股權

Apr 03, 2025 17:30 HKT/SGT

健倍苗苗完成收购天喜堂90%股权

Apr 03, 2025 17:21 HKT/SGT

Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025

Apr 03, 2025 17:00 HKT/SGT

培力農本方公佈2024年年度全年業績公告

Apr 01, 2025 19:00 HKT/SGT

NEC has developed technologies that enable a secure workflow for personalized cancer vaccines and has proven their capabilities

Apr 01, 2025 15:15 HKT/SGT

Eisai to Divest Rights for Pariet in China to Peak Pharma

Apr 01, 2025 12:15 HKT/SGT

Yunkang's Revenue Proportion from Joint Construction Business for Medical Institution Alliances and Special Testing Items Continue to Grow in 2024

Mar 31, 2025 14:31 HKT/SGT

雲康集團2024年醫聯體共建業務及特檢項目收益佔比持續增長

Mar 31, 2025 13:42 HKT/SGT

[Media Alert] Say Goodbye to Brain Fog and Digestive Woes: Recharge with LAC

Mar 30, 2025 01:40 HKT/SGT

Hua Medicine Announces 2024 Annual Results

Mar 28, 2025 21:51 HKT/SGT

華領醫藥公佈2024年全年業績

Mar 28, 2025 21:38 HKT/SGT

华领医药公布2024年全年业绩

Mar 28, 2025 21:28 HKT/SGT

トプコンがMBOにより成長戦略加速、KKRとJICキャピタルが参画

Mar 28, 2025 18:20 JST

エーザイ、アルツハイマー・パーキンソン病学会において、レカネマブの長期実臨床データやバイオマーカーをはじめとするアルツハイマー病の最新成果を発表

Mar 27, 2025 08:40 JST

World's First Early Alzheimer's Disease Treatment Developed in Japan LEQEMBI Receives Prime Minister's Award at the 12th Technology Management and Innovation Awards

Mar 25, 2025 16:28 HKT/SGT

エーザイ、日本発世界初の早期アルツハイマー病治療剤「レケンビ」が第 12 回技術経営・イノベーション大賞において「内閣総理大臣賞」を受賞

Mar 25, 2025 15:30 JST

Eisai Selected as a Nadeshiko Brand 2025 as a Listed Company Excelling in Promotion of Women in the Workplace

Mar 25, 2025 11:21 HKT/SGT